Aktie A950130 ACCESS BIO, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Access Bio, Inc.

Aktien

A950130

KR8840090003

A950130

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 17.06.2024 		% 5 Tage % 1. Jan.
6 960 KRW +3,26 % Intraday Chart für Access Bio, Inc. +4,82 % -22,41 %
2023 Access Bio, Inc. (KOSDAQ:A950130) hat eine unbekannte Minderheitsbeteiligung an CuraPatient Inc. erworben. CI
2023 Access Bio, Inc. meldet Ergebnis für das erste Quartal zum 31. März 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Access Bio, Inc. acquired an unknown minority stake in CuraPatient Inc.
Tranche Update on Access Bio, Inc.'s Equity Buyback Plan announced on March 24, 2022.
Tranche Update on Access Bio, Inc.'s Equity Buyback Plan announced on March 24, 2022.
Tranche Update on Access Bio, Inc.'s Equity Buyback Plan announced on March 24, 2022.
Tranche Update on Access Bio, Inc.'s Equity Buyback Plan announced on March 24, 2022.
Access Bio, Inc. agreed to acquire Belight Investment for approximately KRW 130 billion.
Access Bio, Inc's Equity Buyback announced on March 24, 2022, has expired with 1,840,483 shares, representing 5.22% for KRW 29,899.64 million.
Access Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Access Bio, Inc.'s Equity Buyback Plan Extended till May 23, 2023.
AirBoss Defense Group and Maddox Defense Partner With Access Bio to Deliver US-Made COVID Test Kits to Defense Logistics Agency; BOS Up 2.6%
AirBoss Defense Group and Maddox Defense Partner With Access Bio to Deliver US-Made COVID Test Kits to Defense Logistics Agency
AirBoss of America Brief: Defense Logistics Agency has awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract valued at up to US$410 Million to Access Bio
AirBoss of America Brief: AirBoss Defense Group and Maddox Defense Partner With Access Bio to Deliver US-Made COVID Test Kits to Defense Logistics Agency
QuidelOrtho, Orasure Technologies, Others Share $803 Million Contract From US Defense Logistics Agency
Tranche Update on Access Bio, Inc.'s Equity Buyback Plan announced on March 24, 2022.
Wellysis announced that it has received KRW 5 billion in funding from Access Bio, Inc.
Access Bio, Inc. announces an Equity Buyback for KRW 30,000 million worth of its shares.
Access Bio, Inc. authorizes a Buyback Plan.
Access Bio, Inc. announced that it has received KRW 30 billion in funding from Meritz Securities Co., Ltd.
Access Bio, Inc. announced that it expects to receive KRW 30 billion in funding from Meritz Securities Co., Ltd.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A950130 Aktie
  4. Nachrichten Access Bio, Inc.
  5. Andere Sprachen
-40 % Einmalige Verlängerung: Unsere Abonnements führen Sie zu den besten Investitionen von morgen
PROFITIEREN SIE JETZT